175 related articles for article (PubMed ID: 12472377)
1. Protein tyrosine phosphatases as drug targets: PTP1B and beyond.
Hooft van Huijsduijnen R; Wälchli S; Ibberson M; Harrenga A
Expert Opin Ther Targets; 2002 Dec; 6(6):637-47. PubMed ID: 12472377
[TBL] [Abstract][Full Text] [Related]
2. Protein Tyrosine Phosphatase (PTP1B): A promising Drug Target Against Life-threatening Ailments.
Kumar A; Rana D; Rana R; Bhatia R
Curr Mol Pharmacol; 2020; 13(1):17-30. PubMed ID: 31339082
[TBL] [Abstract][Full Text] [Related]
3. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
Zhang ZY; Lee SY
Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
Koren S; Fantus IG
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
[TBL] [Abstract][Full Text] [Related]
5. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance.
Goldstein BJ
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):265-75. PubMed ID: 12477292
[TBL] [Abstract][Full Text] [Related]
6. Functional studies of protein tyrosine phosphatases with chemical approaches.
Zhang ZY
Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer.
Dubé N; Tremblay ML
Biochim Biophys Acta; 2005 Dec; 1754(1-2):108-17. PubMed ID: 16198645
[TBL] [Abstract][Full Text] [Related]
8. Druggable targets of protein tyrosine phosphatase Family, viz. PTP1B, SHP2, Cdc25, and LMW-PTP: Current scenario on medicinal Attributes, and SAR insights.
Bhavana ; Kohal R; Kumari P; Das Gupta G; Kumar Verma S
Bioorg Chem; 2024 Mar; 144():107121. PubMed ID: 38237392
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
Harley EA; Levens N
Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase 1B inhibitors for diabetes.
Johnson TO; Ermolieff J; Jirousek MR
Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatases in cancer: friends and foes!
Labbé DP; Hardy S; Tremblay ML
Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721
[TBL] [Abstract][Full Text] [Related]
12. NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism.
Sreejayan N; Lin Y; Hassid A
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1086-92. PubMed ID: 12117721
[TBL] [Abstract][Full Text] [Related]
13. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.
Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM
Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489
[TBL] [Abstract][Full Text] [Related]
14. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in protein tyrosine phosphatase 1B inhibitors.
Taylor SD; Hill B
Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
Liu G; Trevillyan JM
Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase beta.
Lund IK; Andersen HS; Iversen LF; Olsen OH; Møller KB; Pedersen AK; Ge Y; Holsworth DD; Newman MJ; Axe FU; Møller NP
J Biol Chem; 2004 Jun; 279(23):24226-35. PubMed ID: 15024017
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions.
Reddy RH; Kim H; Cha S; Lee B; Kim YJ
J Microbiol Biotechnol; 2017 May; 27(5):878-895. PubMed ID: 28238001
[TBL] [Abstract][Full Text] [Related]
19. Protein-tyrosine phosphatase 1B as a potential drug target for obesity.
Dadke S; Chernoff J
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):299-304. PubMed ID: 14683461
[TBL] [Abstract][Full Text] [Related]
20. Modulation of protein kinase signaling by protein phosphatases and inhibitors.
Zhang ZY; Zhou B; Xie L
Pharmacol Ther; 2002; 93(2-3):307-17. PubMed ID: 12191622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
